These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 10605016)
21. TRAIL: a mechanism of tumor surveillance in an immune privileged site. Lee HO; Herndon JM; Barreiro R; Griffith TS; Ferguson TA J Immunol; 2002 Nov; 169(9):4739-44. PubMed ID: 12391182 [TBL] [Abstract][Full Text] [Related]
22. CD44-deficient mice exhibit enhanced hepatitis after concanavalin A injection: evidence for involvement of CD44 in activation-induced cell death. Chen D; McKallip RJ; Zeytun A; Do Y; Lombard C; Robertson JL; Mak TW; Nagarkatti PS; Nagarkatti M J Immunol; 2001 May; 166(10):5889-97. PubMed ID: 11342603 [TBL] [Abstract][Full Text] [Related]
23. Lack of FasL-mediated killing leads to in vivo tumor promotion in mouse Lewis lung cancer. Lee JK; Sayers TJ; Back TC; Wigginton JM; Wiltrout RH Apoptosis; 2003 Mar; 8(2):151-60. PubMed ID: 12766475 [TBL] [Abstract][Full Text] [Related]
24. Potentiation of Fas-mediated apoptosis of murine granulosa cells by interferon-gamma, tumor necrosis factor-alpha, and cycloheximide. Quirk SM; Porter DA; Huber SC; Cowan RG Endocrinology; 1998 Dec; 139(12):4860-9. PubMed ID: 9832422 [TBL] [Abstract][Full Text] [Related]
25. CD8+ tumor-infiltrating lymphocytes are primed for Fas-mediated activation-induced cell death but are not apoptotic in situ. Radoja S; Saio M; Frey AB J Immunol; 2001 May; 166(10):6074-83. PubMed ID: 11342625 [TBL] [Abstract][Full Text] [Related]
26. CD8+ T cells stimulated by exosomes derived from RenCa cells mediate specific immune responses through the FasL/Fas signaling pathway and, combined with GM‑CSF and IL‑12, enhance the anti‑renal cortical adenocarcinoma effect. Xu HY; Li N; Yao N; Xu XF; Wang HX; Liu XY; Zhang Y Oncol Rep; 2019 Aug; 42(2):866-879. PubMed ID: 31233203 [TBL] [Abstract][Full Text] [Related]
27. Functional effects of TNF-alpha on a human follicular dendritic cell line: persistent NF-kappa B activation and sensitization for Fas-mediated apoptosis. Park SM; Park HY; Lee TH J Immunol; 2003 Oct; 171(8):3955-62. PubMed ID: 14530313 [TBL] [Abstract][Full Text] [Related]
28. Peripheral 4-1BB signaling negatively regulates NK cell development through IFN-gamma. Choi BK; Kim YH; Kim CH; Kim MS; Kim KH; Oh HS; Lee MJ; Lee DK; Vinay DS; Kwon BS J Immunol; 2010 Aug; 185(3):1404-11. PubMed ID: 20610645 [TBL] [Abstract][Full Text] [Related]
29. NF-kappa B RelA (p65) is essential for TNF-alpha-induced fas expression but dispensable for both TCR-induced expression and activation-induced cell death. Zheng Y; Ouaaz F; Bruzzo P; Singh V; Gerondakis S; Beg AA J Immunol; 2001 Apr; 166(8):4949-57. PubMed ID: 11290773 [TBL] [Abstract][Full Text] [Related]
30. Antigen-dependent release of IFN-gamma by cytotoxic T cells up-regulates Fas on target cells and facilitates exocytosis-independent specific target cell lysis. Müllbacher A; Lobigs M; Hla RT; Tran T; Stehle T; Simon MM J Immunol; 2002 Jul; 169(1):145-50. PubMed ID: 12077239 [TBL] [Abstract][Full Text] [Related]
31. Silencing of the caspase-1 gene occurs in murine and human renal cancer cells and causes solid tumor growth in vivo. Ueki T; Takeuchi T; Nishimatsu H; Kajiwara T; Moriyama N; Narita Y; Kawabe K; Ueki K; Kitamura T Int J Cancer; 2001 Mar; 91(5):673-9. PubMed ID: 11267979 [TBL] [Abstract][Full Text] [Related]
32. Fas ligand and Fas are expressed constitutively in human astrocytes and the expression increases with IL-1, IL-6, TNF-alpha, or IFN-gamma. Choi C; Park JY; Lee J; Lim JH; Shin EC; Ahn YS; Kim CH; Kim SJ; Kim JD; Choi IS; Choi IH J Immunol; 1999 Feb; 162(4):1889-95. PubMed ID: 9973455 [TBL] [Abstract][Full Text] [Related]
33. Tumor immunity in perforin-deficient mice: a role for CD95 (Fas/APO-1). Rosen D; Li JH; Keidar S; Markon I; Orda R; Berke G J Immunol; 2000 Mar; 164(6):3229-35. PubMed ID: 10706715 [TBL] [Abstract][Full Text] [Related]
34. Role of neutrophils and lymphocytes in inhibition of a mouse mammary adenocarcinoma engineered to release IL-2, IL-4, IL-7, IL-10, IFN-alpha, IFN-gamma, and TNF-alpha. Musiani P; Allione A; Modica A; Lollini PL; Giovarelli M; Cavallo F; Belardelli F; Forni G; Modesti A Lab Invest; 1996 Jan; 74(1):146-57. PubMed ID: 8569177 [TBL] [Abstract][Full Text] [Related]
36. In vivo apoptosis of diabetogenic T cells in NOD mice by IFN-gamma/TNF-alpha. Qin HY; Chaturvedi P; Singh B Int Immunol; 2004 Dec; 16(12):1723-32. PubMed ID: 15492021 [TBL] [Abstract][Full Text] [Related]
37. TRAIL-induced cell death cooperates with IFN-gamma activation in the graft-versus-tumor effect against colon tumors. Tateishi K; Ohta M; Guleng B; Kanai F; Tanaka Y; Asaoka Y; Jazag A; Imamura J; Imamura T; Ijichi H; Ikenoue T; Kawakami T; Fukushima Y; Washida M; Sata M; Miyagishi M; Taira K; Yoshida H; Kawabe T; Omata M Int J Cancer; 2006 May; 118(9):2237-46. PubMed ID: 16331624 [TBL] [Abstract][Full Text] [Related]
38. Trafficking of 'immune' CD4(+)/CD8(+)T-lymphocytes into the RENCA tumour microcirculation in vivo in mice. Ali SA; Rees RC; Anderson DQ; Reed MW; Goepel JR; Brown NJ Br J Cancer; 2000 Oct; 83(8):1061-8. PubMed ID: 10993655 [TBL] [Abstract][Full Text] [Related]
39. Regulation of Fas and Fas ligand expression in cultured murine renal cells and in the kidney during endotoxemia. Ortiz-Arduan A; Danoff TM; Kalluri R; González-Cuadrado S; Karp SL; Elkon K; Egido J; Neilson EG Am J Physiol; 1996 Dec; 271(6 Pt 2):F1193-201. PubMed ID: 8997393 [TBL] [Abstract][Full Text] [Related]
40. Defining the roles of perforin, Fas/FasL, and tumour necrosis factor alpha in T cell induced mucosal damage in the mouse intestine. Merger M; Viney JL; Borojevic R; Steele-Norwood D; Zhou P; Clark DA; Riddell R; Maric R; Podack ER; Croitoru K Gut; 2002 Aug; 51(2):155-63. PubMed ID: 12117872 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]